177 related articles for article (PubMed ID: 15322564)
1. Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands.
McColl SR; Mahalingam S; Staykova M; Tylaska LA; Fisher KE; Strick CA; Gladue RP; Neote KS; Willenborg DO
Lab Invest; 2004 Nov; 84(11):1418-29. PubMed ID: 15322564
[TBL] [Abstract][Full Text] [Related]
2. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.
Narumi S; Kaburaki T; Yoneyama H; Iwamura H; Kobayashi Y; Matsushima K
Eur J Immunol; 2002 Jun; 32(6):1784-91. PubMed ID: 12115662
[TBL] [Abstract][Full Text] [Related]
4. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
5. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.
Clark-Lewis I; Mattioli I; Gong JH; Loetscher P
J Biol Chem; 2003 Jan; 278(1):289-95. PubMed ID: 12417585
[TBL] [Abstract][Full Text] [Related]
7. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.
Loetscher P; Pellegrino A; Gong JH; Mattioli I; Loetscher M; Bardi G; Baggiolini M; Clark-Lewis I
J Biol Chem; 2001 Feb; 276(5):2986-91. PubMed ID: 11110785
[TBL] [Abstract][Full Text] [Related]
8. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.
Cole KE; Strick CA; Paradis TJ; Ogborne KT; Loetscher M; Gladue RP; Lin W; Boyd JG; Moser B; Wood DE; Sahagan BG; Neote K
J Exp Med; 1998 Jun; 187(12):2009-21. PubMed ID: 9625760
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation.
Flier J; Boorsma DM; van Beek PJ; Nieboer C; Stoof TJ; Willemze R; Tensen CP
J Pathol; 2001 Aug; 194(4):398-405. PubMed ID: 11523046
[TBL] [Abstract][Full Text] [Related]
10. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
11. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
Colvin RA; Campanella GS; Sun J; Luster AD
J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
[TBL] [Abstract][Full Text] [Related]
12. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CXCR3: an unexpected enigma.
Liu L; Callahan MK; Huang D; Ransohoff RM
Curr Top Dev Biol; 2005; 68():149-81. PubMed ID: 16124999
[TBL] [Abstract][Full Text] [Related]
15. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.
Cox MA; Jenh CH; Gonsiorek W; Fine J; Narula SK; Zavodny PJ; Hipkin RW
Mol Pharmacol; 2001 Apr; 59(4):707-15. PubMed ID: 11259614
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.
Marx N; Mach F; Sauty A; Leung JH; Sarafi MN; Ransohoff RM; Libby P; Plutzky J; Luster AD
J Immunol; 2000 Jun; 164(12):6503-8. PubMed ID: 10843708
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
18. Rat chemokine CXCL11: structure, tissue distribution, function and expression in cardiac transplantation models.
Mitsuhashi N; Wu GD; Zhu H; Kearns-Jonker M; Cramer DV; Starnes VA; Barr ML
Mol Cell Biochem; 2007 Feb; 296(1-2):1-9. PubMed ID: 17264982
[TBL] [Abstract][Full Text] [Related]
19. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
Colvin RA; Campanella GS; Manice LA; Luster AD
Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
[TBL] [Abstract][Full Text] [Related]
20. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]